Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review

The number of patients on long-term anti-osteoporotic drug therapy is rising. Unfortunately, there are few data to guide decisions about duration of pharmacologic therapy for osteoporosis. Many practitioners discontinue therapy after a period of 5 years because of the risk of rare but severe side ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbers, Laura P. B., Raterman, Hennie G., Lems, Willem F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519894/
https://www.ncbi.nlm.nih.gov/pubmed/34524681
http://dx.doi.org/10.1007/s40265-021-01587-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519894/
https://www.ncbi.nlm.nih.gov/pubmed/34524681
http://dx.doi.org/10.1007/s40265-021-01587-x

Ejemplares similares